Opened 355 days ago

Closes 31 December 2022

Trial Aim Description

Testing a potential new treatment/investigational product for (Inclusion Body Myositis) IBM. The potential new treatment/investigational product is called ABC008.

Trial Eligibility Requirements

Patients must be living with inclusion body myositis (IBM)

Interested? Enquire today

Principal Investigator: Professor Merrilee Needham

View more trials